HOME › Press Releases › Genomics Market worth 19.99 Billion USD by 2020
Genomics Market worth 19.99 Billion USD by 2020
The report "Genomics Market by Product (Instruments, Consumables), by Technology (Sequencing, PCR, Microarray), by Application (Diagnostics, Personalized Medicine), by Process (Library Preparation, Sequencing & Imaging), by End User - Trends & Global Forecasts to 2020" , analyzes and studies the major market drivers, restraints/challenges, and opportunities.
Browse 117 market data Tables and 43 Figures spread through 195 Pages and in-depth TOC on "Genomics Market by Product (Instruments, Consumables), by Technology (Sequencing, PCR, Microarray), by Application (Diagnostics, Personalized Medicine), by Process (Library Preparation, Sequencing & Imaging), by End User - Trends & Global Forecasts to 2020"
Early buyers will receive 10% customization on reports.
This report studies the global genomics market for the forecast period of 2015 to 2020. This market is expected to reach USD 19.99 Billion by 2020 from USD 12.5 Billion in 2015, at a CAGR of 9.9%.
The global genomics market is segmented on the basis of product, technology, process, end user, application, and region.
Based on products, the genomics market is categorized into instruments/systems, consumables, and services. In 2015, the consumables accounted for the larger share of the genomics market and expected to grow at the fastest rate during the forecast period. On the basis of technology, the market is categorized into sequencing, microarray, PCR, nucleic acid extraction and purification, branched DNA analysis, single cell genomics analysis, and flow cytometry, among others. PCR accounted for the largest share of the genomics market in 2015. Based on the process the genomics market is segmented into library preparation; sequencing and imaging; and data analysis. Sequencing and imaging segment contributed for the highest market share in 2015, and is expected to grow at the fastest rate during the forecast period.
The genomics end user market is categorized into academic institutes, research centers, government institutes, hospitals & clinics, pharmaceutical & biotechnology companies, agri-genomic companies, forensic agencies, and fishery & aquaculture firms, among others. The academic institutes, research centers, government institutes accounted for major share of the genomics end users market in 2015. Based on applications, the market is segmented into diagnostics, drug discovery & development, personalized medicine, forensics, and agricultural & animal research, among others. The diagnostics segment accounted for the largest share of the genomics market in 2015 and is projected to grow at the highest CAGR from 2015 to 2020.
On the basis of regions, the global market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (Latin America, Middle East, and Africa). In 2015, North America is poised to account for the largest share of the genomics market, followed by Europe and Asia-Pacific. The North American market is slated to grow at the highest CAGR during the forecast period and serve as a revenue pocket for companies offering genomics products. A boost in demand for genomic products is anticipated in North America due to the passage of Personalized Medicine Initiative in 2015. The new healthcare initiative will increase the adaptation of genomics in personalized medicine and provide better treatment to the patients.
The factors driving the growth of the global genomics market include increasing investments, grants, and funds by the government; increasing research in the field of genomics; increasing number of start-up companies; and increasing application of genomic sequencing in the diagnostics. Despite the large number of benefits like detection of genetic variations in a diseased condition, high costs of genomic sequencing instruments/systems are restraining the genomics market.
Some major players in the global genomics market include Illumina, Inc. (U.S.), Affymetrix, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), BGI (China), Thermo Fisher Scientific, Inc. (U.S.), Bio Rad Laboratories, Inc. (U.S.), Cepheid, Inc. (U.S.), GE Healthcare (U.K.), QIAGEN (Germany), and Roche Diagnostics (Switzerland).
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India